Various studies have demonstrated the increasing prevalence of non-B HIV-1 subtypes in Western Europe. In contrast, knowledge about the molecular epidemiology of HIV-1 in Central and Eastern Europe is limited. The objective of present study was to investigate the HIV-1 molecular diversity as well as
Molecular epidemiology of HIV-1 subtypes and drug resistant strains in Taiwan
✍ Scribed by Yu-Ching Lan; Tarek Elbeik; JoAnn Dileanis; Valerie Ng; Yen-Ju Chen; Hsieh-Shong Leu; Shu-Hsing Cheng; Jen-Chien Wong; Wing-Wai Wong; Yi-Ming A. Chen
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 244 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The Taiwanese government has provided free highly active antiretroviral therapy since April 1997. Previously, we have reported on the molecular epidemiology of HIV‐1 in Taiwan from 1988 to 1998. In addition, an outbreak of circulating recombinant form (CRF) 07_BC among intravenous drug users was noted in 2004. Therefore, the purposes of this study were to elucidate the distribution of HIV‐1 subtypes among different high‐risk groups in Taiwan from 1999 to 2000 and to conduct surveillance on drug resistance among treatment naïve patients from 1997 to 2000. Blood samples from 239 HIV‐1/AIDS patients and their subtypes were examined using DNA sequencing and phylogenetic analysis. The results showed that among 226 male patients, 213 (94.2%) had subtype B, 11 (4.9%) had CRF01_AE, 1 had unique recombinant strain related to both CRF07_BC and CRF08_BC (strain T12‐99TW) and 1 had CRF08_BC (strain L9312‐00TW). The patients infected with T12‐99TW and L9312‐00TW were intravenous drug users and had needle‐sharing experiences in Yunnan Province, China. Of the 13 HIV‐1‐infected females, 7 (53.8%) had subtype B, 5 (38.5%) had CRF01_AE, and 1 (7.7%) had subtype C. Phylogenetic analysis demonstrated that the neither strain T12‐99TW nor L9312‐00TW clustered with CRF07_BC strains isolated from Taiwanese intravenous drug users in 2004. In addition, 126 treatment naïve patients were selected for genotypic DR analysis and the results showed that 4.3% (2/47) homosexual males had M184V mutations. This is the first report on the identification of CRF08_BC and a unique recombinant strain related to both CRF07_BC and CRF08_BC in Taiwan. J. Med. Virol. 80:183–191, 2008. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Recent studies have demonstrated an increased prevalence of human immunodeficiency virus type 1 (HIV‐1) subtype C in southern Brazil. Although Santa Catarina State (SC) is located in this area and presents one of the country's highest incidences of HIV/AIDS, knowledge on the molecular e
Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form (CRF) 07\_BC strain has caused serious outbreaks among injection drug users in Taiwan since 2004. The objective of this study was to conduct a molecular epidemiological study of HCV genotypes in intravenous drug users in Taiwan
## Abstract This study reports the analysis of human immunodeficiency virus type 1 (HIV‐1) protease (PR) and reverse transcriptase (RT) coding sequences from 136 HIV‐1‐infected subjects from Chile, 66 (49%) of them under antiretroviral (ARV) treatment. The prevalence of mutations conferring high or
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
## Abstract Etravirine (ETR) is a non‐nucleoside analogue reverse transcriptase inhibitor (NNRTI) with a high genetic barrier to the development of resistance and with potential activity against __Human immunodeficiency virus type 1__ (HIV‐1) strains resistant to first‐generation NNRTIs. The object